Rapid Dose Therapeutics Corp. (CSE:DOSE)

Canada · Delayed Price · Currency is CAD

0.1500

+0.0150 (11.11%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	Feb '20 Feb 29, 2020	Feb '19 Feb 28, 2019	Feb '18 Feb 28, 2018
Pharmaceuticals	2.09M	1.02M	718.30K	1.75M	755.20K
Pharmaceuticals Growth	104.34%	42.06%	-59.00%	131.98%	644.06%
Total	2.09M	1.02M	718.30K	1.75M	755.20K
Total Growth	104.34%	42.06%	-59.00%	131.98%	644.06%

Revenue by Geography

Financials in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	Feb '20 Feb 29, 2020	Feb '19 Feb 28, 2019	Feb '18 Feb 28, 2018
Canada	2.09M	1.02M	718.30K	1.75M	755.20K
Canada Growth	104.34%	42.06%	-59.00%	131.98%	644.06%
Total	2.09M	1.02M	718.30K	1.75M	755.20K
Total Growth	104.34%	42.06%	-59.00%	131.98%	644.06%

Source: S&P Global Market Intelligence.